Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB360909

Limitin/IFN-zeta Antibody (RM0123-7D19), PerCP, Novus Biologicals™
SDP

Catalog No. NB360909 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB360909 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB360909 Supplier Novus Biologicals Supplier No. NBP212426PCP
Add to Cart
Add to Cart

Description

Rat Monoclonal Antibody

Limitin/IFN-zeta Monoclonal antibody specifically detects Limitin/IFN-zeta in Mouse samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin), Neutralization

Specifications

Antigen Limitin/IFN-zeta
Applications Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin), Neutralization
Classification Monoclonal
Clone RM0123-7D19
Conjugate PerCP
Dilution Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, Block/Neutralize
Formulation PBS
Gene Alias 6030405N23Rik, BGIF, Ifnz, interferon zeta, Lmtn
Host Species Rat
Immunogen Mouse recombinant Limitin/IFN-zeta
Purification Method Protein A or G purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 319146
Target Species Mouse
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG2
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.